Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
How I'd Invest $50,000 for Retirement If I Had to Start From Scratch
07:39am, Thursday, 26'th Jan 2023
Starting with a completely clean slate free of the usual investment baggage is a liberating, insightful exercise.
Earn Dividends Every Month With These 3 Stocks
07:17am, Thursday, 26'th Jan 2023
Having this trio of high-quality companies in your portfolio will ensure that you collect a payout each month.
10 Biggest Companies Reporting Earnings in the First Week of Feb 2023
10:56pm, Wednesday, 25'th Jan 2023
The fourth quarter earnings season for the S&P 500 didn't get off to a strong start.
Grade my trade: MRK, ALLY, MU & GXO
01:57pm, Wednesday, 25'th Jan 2023
CNBC's 'Halftime Report' investment committee, Joe Terranova, Jenny Harrington, Bill Baruch and Steve Weiss, weigh in on the Merck, Ally Financial, Micron, and GXO logistics.
Want to Collect a Dividend Every Month? Buy These 3 High-Yielding Stocks
05:25am, Wednesday, 25'th Jan 2023
You can keep the cash flowing into your portfolio with these above-average payouts.
Merck: Getting Less Attractive
11:50pm, Saturday, 21'st Jan 2023
Merck's underlying progress is solid. MRK has rallied a lot over the last year.
This Dow Jones Stock Crushed the Market in 2022 -- Can It Do It Again?
07:40am, Saturday, 21'st Jan 2023
This pharmaceutical was the second-best performing Dow Jones stock in 2022 behind the energy giant Chevron.
Merck Is A Strong Investment Opportunity For Long-Term Growth
02:24am, Saturday, 21'st Jan 2023
Merck has a strong track record of financial performance and a diverse product portfolio. With a strong commitment to research and development, Merck can stay at the forefront of the industry.
Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence
11:35am, Wednesday, 18'th Jan 2023
Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan?
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 17'th Jan 2023
Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
MDA Breakout Stocks Week 3 - January 2023: High-Frequency Gainers To Give You An Edge
06:24am, Sunday, 15'th Jan 2023
Two new Breakout Stocks for Week 3 with better than 10% short-term upside and two Dow 30 Picks. Average cumulative returns for 2023 are +21.37% YTD. This week 2 of 4 high-frequency breakout picks gain
I'll Avoid These Sectors In 2023
03:39am, Sunday, 15'th Jan 2023
I wrote an article about which sectors I intend to focus on for this year, with a number of example picks for each sector. In this article, it's the opposite. I will show you what sectors I will try t
3 Top Stocks to Buy for the Long Haul
07:50am, Saturday, 14'th Jan 2023
Not too many companies are built not just to last, but to thrive in any and all market environments.
Pick Either Merck Stock Or Its Peer – Both May Offer Similar Returns
08:00am, Friday, 13'th Jan 2023
We believe that pharmaceutical giants Merck stock (NYSE: MRK) and Pfizer stock (NYSE: PFE) will likely offer similar returns over the next three years.
The 5 Best- and Worst-Performing Mega-Cap Stocks in Q4 2022
10:52pm, Thursday, 12'th Jan 2023
Last year was a volatile one for the equity market, with rising interest rates, record high inflation and geopolitical tensions triggering broad-based sell-offs.
